LUMIGAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lumigan, and what generic alternatives are available?
Lumigan is a drug marketed by Abbvie and is included in two NDAs. There are twelve patents protecting this drug and two Paragraph IV challenges.
This drug has thirty-four patent family members in twenty-two countries.
The generic ingredient in LUMIGAN is bimatoprost. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the bimatoprost profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lumigan
A generic version of LUMIGAN was approved as bimatoprost by APOTEX on December 1st, 2014.
Summary for LUMIGAN
International Patents: | 34 |
US Patents: | 12 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Clinical Trials: | 46 |
Patent Applications: | 4,457 |
Drug Prices: | Drug price information for LUMIGAN |
Drug Sales Revenues: | Drug sales revenues for LUMIGAN |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for LUMIGAN |
What excipients (inactive ingredients) are in LUMIGAN? | LUMIGAN excipients list |
DailyMed Link: | LUMIGAN at DailyMed |
Recent Clinical Trials for LUMIGAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Laboratoires Thea | Phase 1 |
Amneal Pharmaceuticals, LLC | Phase 3 |
CBCC Global Research | Phase 3 |
Pharmacology for LUMIGAN
Drug Class | Prostaglandin Analog |
Anatomical Therapeutic Chemical (ATC) Classes for LUMIGAN
Paragraph IV (Patent) Challenges for LUMIGAN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LUMIGAN | Ophthalmic Solution | bimatoprost | 0.01% | 022184 | 1 | 2011-04-05 |
LUMIGAN | Ophthalmic Solution | bimatoprost | 0.03% | 021275 | 1 | 2008-12-22 |
US Patents and Regulatory Information for LUMIGAN
LUMIGAN is protected by thirteen US patents.
Patents protecting LUMIGAN
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF TREATING A PATIENT WITH GLAUCOMA OR OCULAR HYPERTENSION
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF LOWERING INTRAOCULAR PRESSURE IN A PATIENT WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING GLAUCOMA IN A PATIENT
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF TREATING A PATIENT WITH GLAUCOMA OR OCULAR HYPERTENSION
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF REDUCING INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF LOWERING INTRAOCULAR PRESSURE
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF LOWERING INTRAOCULAR PRESSURE
Enhanced bimatoprost ophthalmic solution
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING GLAUCOMA OR ELEVATED INTRAOCULAR PRESSURE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | LUMIGAN | bimatoprost | SOLUTION/DROPS;OPHTHALMIC | 022184-001 | Aug 31, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie | LUMIGAN | bimatoprost | SOLUTION/DROPS;OPHTHALMIC | 022184-001 | Aug 31, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Abbvie | LUMIGAN | bimatoprost | SOLUTION/DROPS;OPHTHALMIC | 022184-001 | Aug 31, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Abbvie | LUMIGAN | bimatoprost | SOLUTION/DROPS;OPHTHALMIC | 022184-001 | Aug 31, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Abbvie | LUMIGAN | bimatoprost | SOLUTION/DROPS;OPHTHALMIC | 022184-001 | Aug 31, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LUMIGAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | LUMIGAN | bimatoprost | SOLUTION/DROPS;OPHTHALMIC | 022184-001 | Aug 31, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | LUMIGAN | bimatoprost | SOLUTION/DROPS;OPHTHALMIC | 022184-001 | Aug 31, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | LUMIGAN | bimatoprost | SOLUTION/DROPS;OPHTHALMIC | 021275-001 | Mar 16, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | LUMIGAN | bimatoprost | SOLUTION/DROPS;OPHTHALMIC | 022184-001 | Aug 31, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | LUMIGAN | bimatoprost | SOLUTION/DROPS;OPHTHALMIC | 021275-001 | Mar 16, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for LUMIGAN
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
AbbVie Deutschland GmbH & Co. KG | Lumigan | bimatoprost | EMEA/H/C/000391 Reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers)., |
Authorised | no | no | no | 2002-03-08 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for LUMIGAN
See the table below for patents covering LUMIGAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 5367946 | ⤷ Try a Trial | |
Japan | 2004346080 | NON-ACIDIC CYCLOPENTANE HEPTANOIC ACID, 2-CYCLOALKYL OR ARYLALKYL DERIVATIVE AS MEDICINE | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 9406433 | ⤷ Try a Trial | |
South Africa | 200707246 | Enhanced bimatoprost ophthalmic solution | ⤷ Try a Trial |
Norway | 337190 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for LUMIGAN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0660716 | CA 2002 00020 | Denmark | ⤷ Try a Trial | |
0660716 | 02C0033 | France | ⤷ Try a Trial | PRODUCT NAME: BIMATOPROST; NAT. REGISTRATION NO/DATE: EU/1/02/205/001 20020308; FIRST REGISTRATION: |
0660716 | SPC/GB02/035 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: BIMATOPROST; REGISTERED: UK EU/1/02/205/001 20020308 |
0660716 | SPC023/2002 | Ireland | ⤷ Try a Trial | SPC023/2002: 20040929, EXPIRES: 20170307 |
0660716 | C300099 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: BIMATOPROST; NAT. REGISTRATION NO/DATE: EU/1/02/205/001 20020308; FIRST REGISTRATION: EU/1/02/205/001 20020308 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |